News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
Presentation CCVVC 2016 Subclinical Leaflet Thrombosis Post-TAVR Presenter: Gian Paolo Ussia June 16, 2016